IRVINE, Calif., June 17, 2005 (PRIMEZONE) -- "The recent acceptance of Xenomics Inc. (OTCBB:XNOM) as a presenter at the annual meeting of the American Association for Clinical Chemistry (AACC) in July affords the company a potent opportunity to showcase its discoveries," stated SmallCap Sentinel analyst, D.R. Clark. "This is a prestigious forum and Xenomics' presentation should be a benchmark in the company's collective efforts. Companies must be approved to present at this conference -- it's a not a simple pay-to-present trade show."
"Obviously, Xenomics must be eager to showcase its accomplishments and possibly garner the attention of industry leading testing laboratories such as Laboratory Corporation of America(r) Holdings (LabCorp(r)), Quest Diagnostics Incorporated, and Specialty Laboratories, Inc.," added Clark.
An informational report regarding Xenomics Inc. has been made available to the public free of charge at: http://www.trilogy-capital.com/xnom_summary.aspx
Individuals may also register free of charge for future reports at the following link: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect the results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.
The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice or research. MP has been paid fifteen hundred dollars by Xenomics, Inc. for preparation and distribution of this report and other advertising services. Additionally, MP and/or its affiliates, associates and employees from time to time may have either a long or short position in any securities mentioned. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.